Nexstim Plc has announced that it is launching its Navigated Brain Therapy (NBT) system in the US for the treatment of Major Depressive Disorder (MDD) at the Clinical TMS (transcranial magnetic stimulation) Society Annual Meeting in New York following FDA clearance for the device in November last year. The Clinical TMS Society Annual Meeting takes place from the 11th to the 13th May, and is a focused conference, bringing together over 500 pa...